S1P1 is a validated target for treatment of autoimmune disease, and functional antagonists with superior safety and pharmacokinetic properties are being sought as second generation therapeutics. We describe the discovery and optimization of (7-benzyloxy-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetic acids as potent, centrally available, direct acting S1P1 functional antagonists, with favorable pharmacokinetic and safety properties.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265824 | PMC |
| http://dx.doi.org/10.1021/ml500422m | DOI Listing |
Publication Analysis
Top Keywords
functional antagonists
12
7-benzyloxy-23-dihydro-1h-pyrrolo[12-a]indol-1-ylacetic acids
8
s1p1 functional
8
acids s1p1
4
antagonists s1p1
4
s1p1 validated
4
validated target
4
target treatment
4
treatment autoimmune
4
autoimmune disease
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!